Search
Search Results
-
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments
Alcohol is a prominent cause of liver disease worldwide with higher prevalence in developed nations. The spectrum of alcohol-associated liver disease...
-
Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement
Most patients with alcohol-associated liver disease (ALD) engage in heavy drinking defined as 4 or more drinks per day (56 g) or 8 (112 g) or more...
-
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action
Alcohol-associated liver disease is currently the leading cause of liver transplantation and liver deaths both in Europe and the United States....
-
Metabolic dysfunction-associated fatty liver disease and heavy alcohol consumption increase mortality:A nationwide study
BackgroundThe effects of excessive alcohol consumption on the prognosis of metabolic dysfunction-associated fatty liver disease (MAFLD) remain...
-
Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD
Background/AimsBariatric surgery can increase the risk of addictive disorders and nutritional deficiencies. The aim of this study was to evaluate the...
-
Micro-scale vertebral features in postmenopausal women with alcohol-associated and metabolic-associated fatty liver disease: ex vivo bone quality analyses
PurposeAlthough epidemiological studies indicate increased fracture risk in women with alcohol-associated liver disease (AALD) and...
-
-
Cytotoxic NK cells phenotype and activated lymphocytes are the main characteristics of patients with alcohol-associated liver disease
T cells, natural killer (NK) and NKT cells have opposing actions in the development of alcohol-associated liver fibrosis. We aimed to evaluate the...
-
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) are the leading causes of chronic liver disease worldwide. NAFLD and...
-
Differences in Bacterial Translocation and Liver Injury in Ethanol Versus Diet-Induced Liver Disease
BackgroundAlcohol-associated liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) are two of the...
-
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) has become the leading cause of liver disease worldwide. NASH, an advanced form of...
-
Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease
IntroductionAbdominal aortic calcifications (AAC) are incidentally found on medical imaging and useful cardiovascular burden approximations. The...
-
Addiction and Liver Disease: Exploring the Complex Relationship and Implications for Clinical Management
Purpose of ReviewThe review focuses on addressing substance use disorders in individuals with chronic liver disease, specifically alcohol, tobacco,...
-
Lifestyle interventions in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a dynamic chronic liver disease that develops in close association with metabolic irregularities. Between...
-
The Global Epidemic of Metabolic Fatty Liver Disease
Purpose of ReviewThe objective of this manuscript is to examine the current literature on the epidemiology of metabolic dysfunction-associated...
-
Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks
Purpose of ReviewThis integrative search aimed to provide a sco** overview of the relationships between the benefits and harms of alcohol drinking...
-
Chronic Liver Disease in the Older Patient—Evaluation and Management
Purpose of ReviewAs our population ages, the number of elderly patients with advanced chronic liver disease (ACLD) will increase. In this review we...
-
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease
Background and aimsIn 2023, a new nomenclature of “metabolic associated steatotic liver disease” (MASLD) has emerged by incorporating...
-
Prevalence of Nonalcoholic Fatty Liver Disease [NAFLD] and Metabolic dysfunction associated Fatty Liver Disease [MAFLD] in patients with Irritable Bowel Syndrome [IBS]
Irritable Bowel Syndrome (IBS) and Nonalcoholic Fatty Liver Disease (NAFLD) are among most sought gastrointestinal and liver related conditions...
